Search

Findings about proteins called molecular chaperones are shedding new light on possible approaches to cancer treatment.

… Thursday, November 10, 2016 Summary New research has shown that proteins called molecular chaperones work together in a communal relationship, suggesting new avenues for targeting their activity. Highlights Molecular chaperones help coordinate important activities inside cells.   Researchers are developing

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.

… Thursday, January 5, 2017 Summary A collaboration among eight leading cancer centers, including MSK, is aiming to take advantage of genomic sequencing of patient tumors to advance the field of precision oncology. On January 5, the group is announcing the release of data on nearly 19,000 cancer patients

Dr. Emmanouil Pappou urges the importance of routine cancer screenings, even during COVID-19, on the TODAY Show.

… Wednesday, November 18, 2020 Fear of COVID-19 has kept people of all ages from getting their routine cancer screenings, including mammograms and colonoscopies . However, rescheduling these vital screenings could be lifesaving. According to the American Cancer Society , more than 150,000 new cases of

It’s rare to meet someone who makes you want to be a better person. Cristy and Alec Fraser are those people — they are inspiring in an extraordinary and life-changing way.

… Thursday, August 26, 2021 It’s rare to meet someone who makes you want to be a better person. Cristy and Alec Fraser are those people — they are inspiring in an extraordinary and life-changing way. On August 15, the Frasers were part of a segment on Good Morning America and then rode their bikes from

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.

… Sunday, June 2, 2019 Summary At this year’s annual meeting of the American Society of Clinical Oncology (ASCO), MSK medical oncologist William Tap talked about disappointing results from olaratumab, a new sarcoma drug that wasn’t shown to increase survival in a recent study. At this year’s American Society

Memorial Sloan Kettering is one of only a few centers in the U.S. to employ liver-directed therapies – using hepatic arterial infusion (HAI) – in conjunction with a number of systemic agents.

… Wednesday, December 7, 2016 There is a real and significant need to improve clinical outcomes in patients with cholangiocarcinoma by building on first-line chemotherapy regimens and developing novel strategies for treatment in the second-line setting. Cholangiocarcinomas are rare malignancies that arise

Memorial Sloan Kettering Cancer Center (MSK) experts presented findings from their latest foundational and translational cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5 to 10 in San Diego.

… Wednesday, April 10, 2024 Memorial Sloan Kettering Cancer Center (MSK) experts presented findings from their latest foundational and translational cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5 to 10 in San Diego. Highlights included discoveries

Nutrition plays an important role in the lives of those who have been diagnosed with cancer. Learn about how treatment can affect what you eat.

… Wednesday, March 21, 2018 Summary Registered dietitian-nutritionist Michelle Myers discusses how to relieve some common symptoms from cancer treatment. Nutrition plays an important role in the lives of those who have been diagnosed with cancer . As people undergo treatment and enter survivorship, their

Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA technology partner have executed a non-exclusive research license and supply agreement to support the development of personalized cancer therapies using Quantoom’s proprietary lipid nanoparticle (LNP) formulation technology, Ncapsulate® QCX-002.

… Thursday, September 25, 2025 Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA technology partner have executed a non-exclusive research license and supply agreement to support

Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.

… Thursday, July 18, 2024   A clinical trial led by exercise scientist Lee Jones, PhD, at Memorial Sloan Kettering Cancer Center suggests that specific amounts of endurance exercise before  surgery  among men with early-stage  prostate cancer can meaningfully improve two key biomarkers associated with